Baseceuticals specializes in providing comprehensive gene therapy solutions that cover a wide range of services, including retroviral vector development, RNA interference (RNAi), and advanced genome editing technologies. We cater to both academic researchers and biopharmaceutical companies by offering innovative, reliable, and customizable gene therapy platforms. Whether you're conducting preclinical research or preparing for clinical applications, our services are designed to accelerate the development of safe and effective gene therapies.